Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma
Authors
Keywords
High-density lipoprotein cholesterol, Extranodal natural killer/T cell lymphoma, Prognosis, Inflammation, Lymphomagenesis
Journal
TUMOR BIOLOGY
Volume 35, Issue 3, Pages 2141-2149
Publisher
Springer Nature
Online
2013-10-12
DOI
10.1007/s13277-013-1284-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma
- (2012) Zhi-Ming Li et al. ANNALS OF HEMATOLOGY
- First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
- (2012) Liang Wang et al. CANCER
- Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients
- (2012) Liang Wang et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Evaluation of serum high-density lipoprotein cholesterol levels as a prognostic factor in gastric cancer patients
- (2012) Takafumi Tamura et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- High numbers of tumor-associated macrophages correlate with poor prognosis in patients with mature T- and natural killer cell lymphomas
- (2012) Ze-Xiao Lin et al. MEDICAL ONCOLOGY
- Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
- (2011) R. Suzuki et al. BLOOD
- Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
- (2011) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience
- (2011) Huiqiang Huang et al. LEUKEMIA & LYMPHOMA
- Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
- (2010) A. Jaccard et al. BLOOD
- Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified
- (2010) Wei Zhang et al. LEUKEMIA & LYMPHOMA
- Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma
- (2009) Y.-X. Li et al. CLINICAL CANCER RESEARCH
- Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma
- (2009) Hyo Song Kim et al. LEUKEMIA & LYMPHOMA
- Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type
- (2008) Biyun Wang et al. AMERICAN JOURNAL OF HEMATOLOGY
- A Clinical Study of 115 Patients with Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
- (2008) X. Wu et al. CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started